Dimensional Fund Advisors LP Y M Abs Therapeutics, Inc. Transaction History
Dimensional Fund Advisors LP
- $363 Billion
- Q1 2024
A detailed history of Dimensional Fund Advisors LP transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 418,699 shares of YMAB stock, worth $5.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
418,699
Previous 313,101
33.73%
Holding current value
$5.06 Million
Previous $2.14 Million
218.88%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding YMAB
# of Institutions
97Shares Held
22.4MCall Options Held
37.4KPut Options Held
48.2K-
Black Rock Inc. New York, NY2.86MShares$34.5 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.23MShares$27 Million1.36% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$26.5 Million2.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.07MShares$25 Million0.0% of portfolio
-
Polar Capital Holdings PLC London, X01.83MShares$22.1 Million0.19% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $528M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...